Sacubitril and Valsartan NDC 70069-855

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-855Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0855Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-855-60	70069085560	60 TABLET, FILM COATED in 1 BOTTLE (70069-855-60)Marketed from Feb 21, 2026
70069-855-80	70069085580	180 TABLET, FILM COATED in 1 BOTTLE (70069-855-80)Marketed from Feb 21, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sacubitril and Valsartan
Generic name (nonproprietary): sacubitril and valsartan
Active ingredients: Sacubitril — 97 mg/1Valsartan — 103 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Somerset Therapeutics, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219983
Marketing start: Feb 21, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Neprilysin Inhibitors (Mechanism)
Identifiers: Product ID 70069-855_0e853a5e-9eab-4bb6-803d-fd9b97e8b550SPL ID 0e853a5e-9eab-4bb6-803d-fd9b97e8b550SPL set ID 4f88efbb-3718-43a1-91d4-da5943ccfca1RxCUI 1656340, 1656349, 1656354UNII 17ERJ0MKGI, 80M03YXJ7IUPC 0370069853801, 0370069855607, 0370069853603, 0370069855805, 0370069854600, 0370069854808
Pharmacologic class: Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470069085560 followed by a unit qualifier and the quantity

Package 70069-0855-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Sacubitril and valsartan tablets are a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. (1.1) for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. Sacubitril and valsartan tablets reduces NT-proBNP and is expected to improve cardiovascular outcomes. (1.2) 1.1 Adult Heart Failure Sacubitril and valsart…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219983

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219983
Product	Strength	Form · route	Labeler	Product NDC
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Somerset Therapeutics, LLC	70069-853
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Somerset Therapeutics, LLC	70069-854